James Garner AKA JG, page-48

Much has been written over a long time about ANP's use for inflammatory diseases. I have just read Platinum Trusts June Quarterly and Bianca Ogden opens up her Commentary chapter with her views about Inflammatory Diseases. She says ........"We are entering the next chapter for inflammatory diseases, and many companies are getting positioned. While there are a number of therapeutic options, none are curative, and response rates as well as the duration of responses need improvement. The landscsape of new drugs in development for anti-inflammatory diseases is vast. Biologics have been a key therapeutic modality in this space, requiring intravenous infusions or frequent injections."

Looks promising for ATL1102 ??